Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer

Acta Chirurgica Belgica

Volumn 107, Issue 3, 2007, Pages 284-287

  Gurleyik, G ^a,c   Gurleyik, E ^b   Aker, F ^a   Aktekin, A ^a   Emir, S ^a   Gungor, O ^a   Saglam, A ^a  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Axilla; Breast cancer; Lymphovascular invasion; Metastasis

Indexed keywords

EID: 34547371605     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2007.11680057     Document Type: Article

References (16)

1. nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 489-514.
2. WOO C. S., SILBERMAN H., NAKAMURA S. K., YE W., COLBURN W., WAISMAN I. R., SILVERSTEIN M. J. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg, 2002, 184: 337-340.
3. DAVIS B. W., GELBER R., GOLDHIRSCH A. et al. Prognostic significance of peritumoural invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol, 1985, 16: 1212-1218.
4. th ed. UK : Langman Group, 1987: 283-284.
5. MCCREADY D. R., CHAPMAN J. A., HANNA W. M. et al. Factors affecting distant disease-free survival for primary invasive breast cancer : use of a log-normal survival model. Ann Surg Oncol, 2000, 7: 416-426.
6. JAGSI R., RAAD R. A., GOLDBERG S. et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy : implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys, 2005, 62: 1035-1039.
7. TRUONG P. T., YONG C. M., ABNOUSI F. et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. J Am Coll Surg, 2005, 200: 912-921.
8. KURU B., CAMLIBEL M., ALI GULCELIK M., ALAGOL H. Prognostic factors affecting survival and disease-free survival in lymph nodenegative breast carcinomas. J Surg Oncol, 2003, 83: 167-172.
9. NERI A., MARRELLI D., ROVIELLO F. et al. Prognostic value of extra-capsular extension of axillary lymph node metastases in T1 to T3 breast cancer. Ann Surg Oncol, 2005, 12: 246-253.
10. TRUDEAU M. E., PRITCHARD K. I., CHAPMAN J. A. et al. Prognostic factors affecting the natural history of node negative breast cancer. Breast Cancer Res Treat, 2005, 89: 35-45.
11. RIVERS A. K., GRIFFITH K. A., HUNT K. K. et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol, 2006, 13: 36-44.
12. SHEN J., HUNT K. K., MIRZA N. Q. et al. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumour recurrence. Cancer, 2005, 104: 479-490.
13. TAN Y. Y., WU C. T., FAN Y. G. et al. Primary tumour characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J, 2005, 11: 338-343.
14. CALLEJO I. P., BRITO J. A., BIWAR J. W. et al. Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transl Oncol, 2005, 7: 18-22.
15. CAO Y., PANER G. P., RAJAN P. B. Sentinel node status and tumour characteristics : a study of 234 invasive breast carcinomas. Arch Pathol Lab Med, 2005, 129: 82-84.
16. SCHOPPMANN S. F., BAYER G., AUMAYR K. et al. Austrian Breast and Colorectal Cancer Study Group. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg, 2004, 240: 306-312.